Extracellular Release of Annexin A2 is Enhanced upon Oxidative Stress Response via the p38 MAPK Pathway after Low-Dose X-Ray Irradiation

Abstract

The extracellular microenvironment affects cellular responses to various stressors including radiation. Annexin A2, which was initially identified as an intracellular molecule, is also released into the extracellular environment and is known to regulate diverse cell surface events, however, the molecular mechanisms underlying its release are not well known. In this study, we found that in cultured human cancer and non-cancerous cells an extracellular release of annexin A2 was greatly enhanced 1-4 h after a single 20 cGy X-ray dose, but not after exposure to ultraviolet C (UVC) radiation. Extracellular release of annexin A2 was also enhanced after H2O2 and nicotine treatments, which was suppressed by pretreatment with the antioxidant, N-acetyl cysteine. Among the oxidative stress pathway molecules examined in HeLa cells, AMP-activated protein kinase α (AMPKα) and p38 mitogen-activated protein kinase (MAPK) were mostly activated by low-dose X-ray radiation, and the p38 MAPK inhibitor, SB203580, but not compound C (an AMPKα inhibitor), suppressed the enhancement of the annexin A2 extracellular release after low-dose X irradiation. In addition, the enhancement was suppressed in the cells in which p38α MAPK was downregulated by siRNA. HeLa cells and human cultured cells preirradiated with 20 cGy or precultured in media from low-dose X-irradiated cells showed an increase in resistance to radiation-induced cell death, and the increase was suppressed by treatment of the irradiated cell-derived media with anti-annexin A2 antibodies. In addition, extracellularly added recombinant annexin A2 conferred cellular radiation resistance. These results indicate that an oxidative stress-activated pathway via p38 MAPK was involved in the extracellular release of annexin A2, and this pathway was stimulated by low-dose X-ray irradiation. Furthermore, released annexin A2 may function in low-dose ionizing radiation-induced responses, such as radioresistance.

Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis

“…Western blotting was performed as previously reported 30 using specific monoclonal antibodies against TFPI2 (#sc‐48380, Santa Cruz Biotechnology). Expression of actin (#ab14128, Abcam) was measured as a loading control.…”

p38MAPK Signaling Pathway in Osteoarthritis: Pathological and Therapeutic Aspects

“…These stimuli include but are not limited to inflammatory factors and cytokines in the articular fluid, changes of osmotic pressure, changes of biological stress and rays. [23][24][25] The activation of MAPKKK is followed by the phosphorylation of the double sites of Thr (tyrosine) and Tyr (threonine) on the "T-ring structure" of p38MAPK, which is executed by MKK3/ MKK6. Then, p38MAPK will be activated subsequently.…”

Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer

“…Western blotting was performed as previously described [17] , using antibodies against AR (#06-680, Millipore, Billerica, MA), AR-V7 (#31-1109-00, RevMAb Biosciences, South San Francisco, CA), SLC3A2 (#15193-1-AP, Proteintech Group, Rosemont, IL), SLC7A5 (#sc-374232, Santa Cruz Biotechnology), and NUP210 (#A301-795A, Bethyl Laboratories, Montgomery, TX). Antibodies against Actin (#ab14128, Abcam, Cambridge, MA), Lamin A and Aldolase (#sc-20680 and #sc-12059, Santa Cruz Biotechnology, Santa Cruz, CA) were used as loading control for whole cell lysates, nuclear proteins, and cytoplasmic protein, respectively.…”